1. Home
  2. RITM vs BLLN Comparison

RITM vs BLLN Comparison

Compare RITM & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rithm Capital Corp.

RITM

Rithm Capital Corp.

HOLD

Current Price

$8.46

Market Cap

4.8B

Sector

Real Estate

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$101.58

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RITM
BLLN
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.6B
IPO Year
2012
2025

Fundamental Metrics

Financial Performance
Metric
RITM
BLLN
Price
$8.46
$101.58
Analyst Decision
Strong Buy
Buy
Analyst Count
11
8
Target Price
$13.00
★ $129.00
AVG Volume (30 Days)
★ 6.4M
527.4K
Earning Date
10-23-2026
11-04-2026
Dividend Yield
★ 11.55%
N/A
EPS Growth
N/A
★ 103.40
EPS
0.16
★ 0.48
Revenue
★ $4,590,228,000.00
$305,112,000.00
Revenue This Year
$54.48
$49.05
Revenue Next Year
$7.79
$26.16
P/E Ratio
★ $53.97
$204.23
Revenue Growth
N/A
★ 99.97
52 Week Low
$8.31
$61.96
52 Week High
$12.15
$150.44

Technical Indicators

Market Signals
Indicator
RITM
BLLN
Relative Strength Index (RSI) 33.79 48.81
Support Level $8.43 $88.85
Resistance Level $9.49 $108.50
Average True Range (ATR) 0.22 6.85
MACD 0.01 -0.56
Stochastic Oscillator 13.89 40.14

Price Performance

Historical Comparison
RITM
BLLN

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: